ORIC ORIC Pharmaceuticals, Inc.

12.01USD+0.25%Mkt Cap: 1.24B $P/E: —

ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies to counter the resistance mechanisms in cancers in the United States. Its clinical stage produ…

Key Statistics

Company
Market Cap1.24B USD
Enterprise Value983.00M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-129.47M USD
Revenue/Share—
Last Price12.01 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees111
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-7.16
PEG—
EV/EBITDA-6.34
EV/Revenue—
P/S—
P/B3.26
EPS (TTM)-1.32
EPS (Forward)-1.67
52W Range
7.23062% of range14.93
52W High14.93 USD
52W Low7.230 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-33.68%
ROA-31.66%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-110.97M USD
CapEx (TTM)712.00K USD
FCF Margin—
FCF Yield-5.53%
Net Debt-258.76M USD
Net Debt/EBITDA1.67
Balance Sheet
Debt/Equity0.01
Current Ratio13.19
Quick Ratio12.76
Book Value/Sh3.68 USD
Cash/Share2.55 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)21.43 USD
Upside (mean)+78.4%
Target Range14.00 USD – 27.00 USD
14.00+78.4% to mean27.00
# Analysts14
Ownership
Shares Out.103.65M
Float88.69M
Insiders1.59%
Institutions123.12%
Short Interest
Short Ratio15.0d
Short % Float17.09%
Short % Out.16.91%
Shares Short17.53M
Short (prev mo.)18.39M
Technical
SMA 5012.97 (-7.4%)
SMA 20010.85 (+10.6%)
Beta0.98
S&P 52W Chg16.45%
Avg Vol (30d)1.38M
Avg Vol (10d)1.62M
Technical Indicators
RSI (14)42.0
MACD-0.0984
MACD Signal0.0540
MACD Hist.-0.1523
BB Upper13.76 USD
BB Middle12.72 USD
BB Lower11.67 USD
BB Width16.43%
ATR (14)0.7759 USD
Vol Ratio (20d)0.51x